SEI Q3 2026 slides: record sales drive 24% earnings growth

SEI reported Q3 2026 adjusted EPS of $1.64, up 24% year over year and above analyst estimates, on revenue of $662 million, up 14.4%; adjusted operating margin expanded 260 bps to 31.5%. Net sales events of $46.8 million lifted year-to-date sales to a record $157 million, while the company repurchased $215 million of stock during the quarter. Institutional Investors was the only segment with lower revenue, and GAAP EPS of $1.38 included a $33 million charge for terminating a planned Mexican RIA acquisition; shares rose to $109.61 in after-hours trading.

Analysis

The key risk to the bullish read is a timing gap: record sales events are pipeline evidence, not current revenue. If mandates take longer to fund, the stock may be priced for operating leverage before the revenue arrives. The flat AUM base, Institutional outflows and LSV’s reported outflows temper the headline strength; moreover, Investment Advisors’ revenue growth is not yet translating into comparable profit growth, leaving integration and investment costs to monitor.

Near term, buybacks and strong margins can support EPS, but the move toward the 52-week high raises the bar for another positive surprise. The $33 million acquisition-termination charge also highlights execution risk in growth initiatives, even if it is excluded from adjusted EPS. Over the next 1–3 months, funded mandates, Carlyle launches and Q4 sales conversion are the cleaner catalysts. Over 6–18 months, ETF growth and broader technology/data engagements could improve the mix, but management’s growth claims need validation in reported assets and recurring revenue.

Contrarian view: the market may be over-weighting sales momentum and under-weighting conversion time, concentration in alternative managers, and weak asset flows. Conversely, if new mandates fund on schedule, current institutional outflows could prove a lagging rather than leading indicator. Watch funded assets, recurring revenue, segment operating profit and compensation-adjusted margins. Thesis weakens if sales fail to convert while margins contract, or if Institutional/LSV outflows persist.

Key Decisions for Investors

• Do not chase the initial post-results strength near the 52-week high. Consider a staged long in SEIC on a pullback or after evidence that sales are converting into funded mandates; valuation data are not provided, so avoid assigning a price target.
• Use Q4 reporting and subsequent updates as a 1–3 month catalyst check: track funded assets, recurring commitments converting to revenue, and Institutional flows. Strong sales events without conversion would invalidate the near-term growth thesis.
• For a 6–18 month holding period, retain exposure only if ETF assets and transfer-agency launches translate into disclosed revenue or assets, while consolidated margins remain resilient after incentive compensation.
• Monitor Investment Advisors’ operating profit against revenue growth and LSV/Institutional flows. Persistent margin dilution or continued outflows would argue for reducing exposure rather than treating record sales as sufficient evidence.